What Solstice Health does
Solstice Health runs an AI-native platform for pharmaceutical and life-sciences marketing teams that unifies content creation, medical-legal-regulatory (MLR) review, and performance insights in one system. The company says its AI grounds every marketing claim in clinical evidence before MLR review, cutting content approval timelines from roughly three months to 10 days or less, and delivering what it describes as 15x cost savings and 12x faster time-to-market for biopharma brands. Solstice Health was co-founded in 2023 by CEO Aris Saxena and Yiwen Li and is headquartered in New York.
Solstice Health is a marketing tool on Falcoscan. AI platform that speeds compliant pharma marketing content through medical-legal review. Falcoscan rates Solstice Health with an Opportunity score of 68/100, a Saturation score of 49/100, and a Wrapper-risk score of 30/100. Market signal: rising. Solstice Health is founded in 2023, currently at Series_a stage. Pricing: Paid.